BRIEF published on 01/20/2026 at 07:35, 9 days 16 hours ago Nicox announces its participation in several congresses in 2026 Glaucoma Ophthalmology Nicox NCX 470 Congress 2026
BRIEF published on 01/20/2026 at 07:35, 9 days 16 hours ago Nicox Announces 2026 Conference Participation and Data Presentations Scientific Data Ophthalmology NCX 470 Conference Participation 2026 Events
PRESS RELEASE published on 01/20/2026 at 07:30, 9 days 16 hours ago Nicox Announces Conference Attendance in H1 2026 and Upcoming Scientific Data Presentations Nicox to attend key ophthalmology conferences and present scientific data at AGS 2026 Annual Meeting. Management team available for meetings. Developing innovative eye health solutions Conference Scientific Data Ophthalmology Nicox Eye Health
BRIEF published on 12/16/2025 at 07:35, 1 month 13 days ago Nicox Finalizes Key Data for NCX 470 NDA Submission by H1 2026 Clinical Trials Ophthalmology Nicox NCX 470 NDA Submission
PRESS RELEASE published on 12/16/2025 at 07:30, 1 month 13 days ago Nicox Completes NCX 470 New Drug Application Key Data Generation for Submission as Planned in H1 2026 Nicox completes key data generation for NCX 470 new drug application submission in H1 2026, including clinical trial and stability data. U.S. and China submissions on track FDA Clinical Trials Nicox NCX 470 New Drug Application
BRIEF published on 10/23/2025 at 07:35, 3 months 6 days ago Nicox Releases First Half 2025 Financial Results Financial Results Debt Repayment Ophthalmology Cost Control NCX 470
PRESS RELEASE published on 10/23/2025 at 07:30, 3 months 6 days ago Nicox Provides First Half 2025 Financial Results Nicox provides first half 2025 financial results, expects NDA submissions for NCX 470 in 2026. Company aims to finance operations for 12 months and repay debts by 2026 Financial Results Debt Repayment Nicox NCX 470 NDA Submissions
BRIEF published on 10/02/2025 at 07:35, 3 months 27 days ago Nicox: Positive results for NCX 470 in the Denali study Clinical Trial Ophthalmology Nicox NCX 470 Intraocular Pressure
PRESS RELEASE published on 10/02/2025 at 07:30, 3 months 27 days ago Nicox’s NCX 470 Demonstrates Sustained Efficacy through 12 Months in Denali Clinical Trial with no new Safety Observations Nicox's NCX 470 shows sustained efficacy with no new safety concerns in Denali trial. Data presented at upcoming ophthalmology conferences Nicox NCX 470 Denali Trial Ophthalmology Conferences Sustained Efficacy
BRIEF published on 09/04/2025 at 07:35, 4 months 25 days ago Nicox Plans Debt Repayment with NCX 470 Progress Debt Repayment Ophthalmology Licensing Nicox NCX 470
Published on 01/30/2026 at 00:00, 4 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/29/2026 at 23:00, 1 hour 4 minutes ago PPX Mining Announces Filing of 2025 Audited Financial Statements and MD&A
Published on 01/29/2026 at 18:45, 5 hours 19 minutes ago Silver Spruce Appoints Vice-President of Exploration
Published on 01/29/2026 at 18:00, 6 hours 4 minutes ago PPX Mining Announces Grant of Restricted Share Units and Deferred Share Units
Published on 01/29/2026 at 17:00, 7 hours 4 minutes ago Sparta Reports on Delay in Filing Annual Financial Statements
Published on 01/29/2026 at 21:02, 3 hours 1 minute ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/29/2026 at 20:59, 3 hours 4 minutes ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 01/29/2026 at 20:57, 3 hours 6 minutes ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 01/29/2026 at 18:00, 6 hours 4 minutes ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 6 hours 19 minutes ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 6 hours 19 minutes ago Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 10:07, 13 hours 56 minutes ago Deezer confirms demonetization of up to 85% of AI-music streams due to fraud and moves to sell AI-detection tech
